About: Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is based in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.51 (-5.10%)
JSPR NASDAQ Jasper Therapeutics Inc
Jasper Therapeutics Inc share price
Atividade de preço de JSPR
Último preço
$ 0,530
Variação (24h)
-0,01 USD (1,26%)
Volume
413.08K
Volume (média 4 sem.)
-
Abertura
$ 0,53
Variação do dia
$ 0,51 - $ 0,56
Fechamento anterior
$ 0,54
Último negócio
29 Oct, 8:12 pm GMT+0
Atrasado
29 Oct, 8:12 pm GMT+0
JSPR price performance
Atrasado
29 Oct, 8:12 pm GMT+0
quote.marketSignals